Truist raised the firm’s price target on Pacs Group (PACS) to $40 from $32 and keeps a Buy rating on the shares. The firm remains bullish on the stock following upbeat management meetings highlighting the company’s strong positioning, enhanced compliance/regulatory rigor post completion of the internal investigation, and attractive underlying trends, the analyst tells investors in a research note. Ongoing expansion activity further complements the solid core trends at Pacs, Truist added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACS:
